Health ❯ Healthcare ❯ Pharmaceuticals

Drug Safety

Mifepristone Contaminated Drugs Product Recalls Counterfeit Medications Product Recall Medication Recall Contaminated Medications Side Effects Contaminated Products Adverse Effects

Largest Danish Study Finds No Autism Risk From Acetaminophen Use in Pregnancy

The findings contradict recent U.S. warnings urging pregnant patients to skip Tylenol.

Viatris Recalls One Lot of Xanax XR Nationwide After Tablets Fail FDA Dissolution Test

Lilly’s Oral Foundayo Matches Insulin on Heart Safety in Major Diabetes Trial

FDA Orders Post-Approval Safety Studies for Lilly’s Foundayo Weight-Loss Pill

Judge Pauses Louisiana Challenge, Leaves Mail-Order Abortion Pill Policy Intact

Insmed Halts Brensocatib in Hidradenitis Suppurativa After Phase 2b Trial Fails

Sanofi’s Dual-Target Nanobody Hits Phase 2 Goals in Asthma and Nasal Polyps

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

FDA Flags 76 Liver Injuries Linked to Amgen’s Tavneos, Urges Tight Monitoring

GOP Senators Press FDA on Illegal Online Abortion Pill Sales, Launch Probe of Mifepristone Makers

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

FDA Upgrades Children’s Ibuprofen Recall to Class II Over Reports of Foreign Material

Lilly Urges Recall After Finding New Impurity in Compounded Tirzepatide With B12

FDA Warns Novo Nordisk Over Missed Reporting of Serious Semaglutide and GLP-1 Adverse Events

New Study Finds Nearly Fivefold Higher Reported ‘Eye Stroke’ Risk With Wegovy vs Ozempic

FOI Reveals Two Suspected GLP‑1 Drug Deaths in Northern Ireland

Lockout Supplements Recalls ‘Boner Bears’ Chocolate Syrup Nationwide After FDA Finds Undeclared Sildenafil

DCA Seizes ₹8 Lakh in Drugs, Uncovers Alleged Label Tampering in NTR District

Anvisa Logs 65 Suspected Deaths Linked to GLP-1 Weight-Loss Injections in Brazil

EU Regulators Recommend EU-Wide Withdrawal of Levamisole Medicines Over Brain Risk